BIOB insider filings
BIO-RAD LABORATORIES, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2025-04-25. Screen BIOB transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for BIOB between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — BIO-RAD LABORATORIES, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-04-25 | 4 | Lakkaraju Roop Kalyan — EVP, Chief Financial Officer | Option exercise (M): 1,077 @ $0 · Tax withholding (F): 386 @ $249.74 · Option exercise (M): 1,077 (derivative) @ $0 | EDGAR |
| 2025-04-25 | 4 | ENLOE COURTNEY C — EVP, General Counsel & Sec | Option exercise (M): 186 @ $0 · Tax withholding (F): 67 @ $249.74 · Option exercise (M): 186 (derivative) @ $0 | EDGAR |
| 2024-10-25 | 4 | DiVincenzo Jonathan P. — President & COO | Grant/award (A): 7,478 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4 | EVRAN SEDAT — EVP, Global Supply Chain | Option exercise (M): 1,044 @ $0 · Tax withholding (F): 335 @ $346.37 · Option exercise (M): 1,044 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | ENGELHARDT EVA ANETTE — EVP, President, CDG | Grant/award (A): 4,608 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | ENLOE COURTNEY C — EVP, General Counsel & Sec | Grant/award (A): 3,072 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | Lakkaraju Roop Kalyan — EVP, Chief Financial Officer | Grant/award (A): 6,143 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | EVRAN SEDAT — EVP, Global Supply Chain | Grant/award (A): 3,456 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | SCHWARTZ NORMAN D — Chairman & CEO, Director, 10% owner | Grant/award (A): 13,822 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | Last Andrew J. — EVP, Chief Operating Officer | Option exercise (M): 3,000 @ $299.24 · Sale (S): 3,000 @ $329.94 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | Allison Schwartz — Director | Grant/award (A): 369 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | COREY COLLEEN — EVP, Global Human Resources | Grant/award (A): 2,304 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | BARRY JAMES — EVP, President, LSG | Grant/award (A): 4,224 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | Crowley Michael — EVP, GBL Commercial Operations | Grant/award (A): 3,456 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | HINCKLEY GREGORY K — Director | Grant/award (A): 308 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | PINKSTON ARNOLD A — Director | Grant/award (A): 308 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | PEI MELINDA LITHERLAND — Director | Grant/award (A): 308 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | EDWARDS JEFFREY L — Director | Grant/award (A): 308 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | Crowley Michael — EVP, GBL Commercial Operations | Option exercise (M): 751 @ $0 · Tax withholding (F): 268 @ $337.32 · Option exercise (M): 520 @ $0 · Tax withholding (F): 218 @ $337.32 · Option exercise (M): 405 @ $0 · Tax withholding (F): 145 @ $337.32 · +9 more | EDGAR |
| 2024-09-04 | 4 | SCHWARTZ NORMAN D — Chairman, President, and CEO, Director, 10% owner | Option exercise (M): 3,005 @ $0 · Tax withholding (F): 1,607 @ $337.32 · Option exercise (M): 2,081 @ $0 · Tax withholding (F): 801 @ $337.32 · Option exercise (M): 1,266 @ $0 · Tax withholding (F): 545 @ $337.32 · +9 more | EDGAR |
| 2024-09-04 | 4 | BARRY JAMES — EVP, President, LSG | Option exercise (M): 250 @ $0 · Tax withholding (F): 90 @ $337.32 · Option exercise (M): 173 @ $0 · Tax withholding (F): 62 @ $337.32 · Option exercise (M): 177 @ $0 · Tax withholding (F): 64 @ $337.32 · +10 more | EDGAR |
| 2024-09-04 | 4 | COREY COLLEEN — EVP, Global Human Resources | Option exercise (M): 500 @ $0 · Tax withholding (F): 179 @ $337.32 · Option exercise (M): 347 @ $0 · Tax withholding (F): 124 @ $337.32 · Option exercise (M): 253 @ $0 · Tax withholding (F): 91 @ $337.32 · +9 more | EDGAR |
| 2024-09-04 | 4 | Allison Schwartz — Director | Option exercise (M): 74 @ $0 · Tax withholding (F): 35 @ $337.32 · Option exercise (M): 42 @ $0 · Tax withholding (F): 20 @ $337.32 · Option exercise (M): 31 @ $0 · Tax withholding (F): 15 @ $337.32 · +9 more | EDGAR |
| 2024-09-04 | 4 | Last Andrew J. — EVP, Chief Operating Officer | Option exercise (M): 1,252 @ $0 · Tax withholding (F): 635 @ $337.32 · Option exercise (M): 867 @ $0 · Tax withholding (F): 440 @ $337.32 · Option exercise (M): 633 @ $0 · Tax withholding (F): 321 @ $337.32 · +6 more | EDGAR |
| 2024-08-28 | 4 | Allison Schwartz — Director | Gift (G): 57 @ $0 | EDGAR |
| 2024-08-28 | 4 | SCHWARTZ STEVEN D — 10% owner | Gift (G): 57 @ $0 · Gift (G): 57 @ $0 | EDGAR |
| 2024-08-28 | 4 | SCHWARTZ NORMAN D — Chairman, President, and CEO, Director, 10% owner | Gift (G): 57 @ $0 · Gift (G): 57 @ $0 | EDGAR |
| 2024-08-28 | 4 | SCHWARTZ ALICE N — 10% owner | Gift (G): 3,190 @ $0 · Gift (G): 342 @ $0 | EDGAR |
| 2024-07-29 | 4 | ENGELHARDT EVA ANETTE — EVP, President, CDG | Grant/award (A): 983 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Crowley Michael — EVP, GBL Commercial Operations | Sale (S): 369 @ $281.91 | EDGAR |
| 2024-05-01 | 4 | SCHWARTZ STEVEN D — 10% owner | Sale (S): 320 @ $463.86 | EDGAR |
| 2024-04-30 | 4 | Last Andrew J. — EVP, Chief Operating Officer | Option exercise (M): 1,000 @ $0 · Tax withholding (F): 357 @ $277.11 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-04-29 | 4 | Lakkaraju Roop Kalyan — EVP, Chief Financial Officer | Grant/award (A): 4,311 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | ERNST TIMOTHY S — EVP, General Counsel & Sec | Grant/award (A): 2,357 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Last Andrew J. — EVP, Chief Operating Officer | Grant/award (A): 5,891 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | MAY SIMON — EVP, President, LSG | Grant/award (A): 3,535 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | COREY COLLEEN — EVP, Global Human Resources | Grant/award (A): 2,357 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | EVRAN SEDAT — EVP, Global Supply Chain | Grant/award (A): 3,535 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | SCHWARTZ NORMAN D — Chairman, President, and CEO, Director, 10% owner | Grant/award (A): 14,137 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Crowley Michael — EVP, GBL Commercial Operations | Grant/award (A): 3,535 (derivative) @ $0 | EDGAR |
| 2024-02-29 | 4 | ERNST TIMOTHY S — EVP, General Counsel & Sec | Option exercise (M): 2,500 @ $326.15 · Sale (S): 2,500 @ $330.55 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2024-02-28 | 4 | Crowley Michael — EVP, GBL Commercial Operations | Option exercise (M): 3,000 @ $215.98 · Sale (S): 3,000 @ $336 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2023-12-19 | 4 | WRIGHT DARA — EVP, President, CDG | Option exercise (M): 502 @ $0 · Tax withholding (F): 174 @ $306.12 · Option exercise (M): 502 (derivative) @ $0 | EDGAR |
| 2023-12-14 | 4 | SCHWARTZ STEVEN D — 10% owner | Gift (G): 49 @ $0 · Gift (G): 49 @ $0 | EDGAR |
| 2023-12-12 | 4 | WRIGHT DARA — EVP, President, CDG | Sale (S): 1,200 @ $299.16 | EDGAR |
| 2023-12-08 | 4 | Allison Schwartz — Director | Gift (G): 49 @ $0 | EDGAR |
| 2023-12-07 | 4 | SCHWARTZ NORMAN D — Chairman, President, and CEO, Director, 10% owner | Gift (G): 49 @ $0 · Gift (G): 49 @ $0 | EDGAR |
| 2023-12-07 | 4 | SCHWARTZ ALICE N — 10% owner | Gift (G): 3,270 @ $0 · Gift (G): 294 @ $0 | EDGAR |
| 2023-11-28 | 4 | Crowley Michael — EVP, GBL Commercial Operations | Sale (S): 642 @ $305.10 | EDGAR |
| 2023-11-02 | 4 | SCHWARTZ NORMAN D — Chairman, President, and CEO, Director, 10% owner | Option exercise (M): 35,000 @ $119.80 · Tax withholding (F): 25,642 @ $273 · Option exercise (M): 16,000 @ $139.56 · Tax withholding (F): 12,274 @ $273 · Option exercise (M): 15,000 @ $159.32 · Tax withholding (F): 12,024 @ $273 · +3 more | EDGAR |
Recent 8-K events — BIO-RAD LABORATORIES, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-04 | 8-K | 2.02 — Results of Operations and Financial Condition ? 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-19 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-02-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-29 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-30 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-26 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-31 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BIOB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs